The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer

References

• PolveriniPJAngiogenesis and wound healing: basic discoveries, clinical implications, and therapeutic opportunitiesEndod Top2011241130145
   Google Scholar
• DiPietroLAAngiogenesis and scar formation in healing woundsCurr Opin Rheumatol2013251879123114588
   PubMed Web of Science ®Google Scholar
• DemirRYabaAHuppertzBVasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantationActa Histochem2010112320321419481785
   PubMed Web of Science ®Google Scholar
• Abu El-AsrarAMNawazMIKangaveDSiddiqueiMMOlaMSOpdenakkerGAngiogenesis regulatory factors in the vitreous from patients with proliferative diabetic retinopathyActa Diabetol201350454555121947384
   PubMedGoogle Scholar
• ZhouJWangSXiaXRole of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathyCurr Eye Res201237541642022409294
   PubMed Web of Science ®Google Scholar
• TammelaTEnholmBAlitaloKPaavonenKThe biology of vascular endothelial growth factorsCardiovasc Res200565355056315664381
   PubMed Web of Science ®Google Scholar
• WangYYaoXGeJHuFZhaoYCan vascular endothelial growth factor and microvessel density be used as prognostic biomarkers for colorectal cancer? A systematic review and meta-analysisScientificWorldJournal2014201410273625143961
   PubMedGoogle Scholar
• BokhmanJVTwo pathogenetic types of endometrial carcinomaGynecol Oncol198315110176822361
   PubMed Web of Science ®Google Scholar
• Cancer.org [homepage on the Internet]2017 American Cancer Society, Inc Available from: http://www.cancer.org/cancer/endometrialcancer/detailedguide/endometrial-uterine-cancer-key-statisticsAccessed 4 January 2017
   Google Scholar
• NaumovGNAkslenLAFolkmanJRole of angiogenesis in human tumor dormancy: animal models of the angiogenic switchCell Cycle20065161779178716931911
   PubMed Web of Science ®Google Scholar
• NaumovGNFolkmanJStraumeOTumor dormancy due to failure of angiogenesis: role of the microenvironmentClin Exp Metastasis2009261516018563595
   PubMed Web of Science ®Google Scholar
• NaumovGNFolkmanJStraumeOAkslenLATumor-vascular interactions and tumor dormancyApmis20081167–856958518834403
   PubMedGoogle Scholar
• FolkmanJRole of angiogenesis in tumor growth and metastasisSemin Oncol20026Suppl 161518
   Google Scholar
• GelaoLCriscitielloCFumagalliLTumour dormancy and clinical implications in breast cancerEcancermedicalscience2013732023717341
   PubMedGoogle Scholar
• YamazakiYMoritaTMolecular and functional diversity of vascular endothelial growth factorsMol Divers200610451552716972015
   PubMedGoogle Scholar
• FerraraNGerberHPLeCouterJThe biology of VEGF and its receptorsNat Med20039666967612778165
   PubMed Web of Science ®Google Scholar
• LaiTHVlahosNShihIMZhaoYExpression patterns of VEGF and Flk-1 in human endometrium during the menstrual cycleJ Reprod Infertil20151613925717429
   PubMedGoogle Scholar
• ZhangXQiCLinJEnhanced expressions of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleedingFertil Steril20109372362236719249761
   PubMed Web of Science ®Google Scholar
• ChristofferssonGVågesjöEVandoorenJVEGF-A recruits a proangiogenic MMP-9–delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissueBlood2012120234653466222966168
   PubMed Web of Science ®Google Scholar
• LucasTWaismanARanjanRDifferential roles of macrophages in diverse phases of skin repairJ Immunol201018473964397720176743
   PubMed Web of Science ®Google Scholar
• ChangCWerbZThe many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasisTrends Cell Biol20011111S37S4311684441
   PubMedGoogle Scholar
• ZítkaOKukackaJKrizkovSMatrix metalloproteinasesCurr Med Chem201017313751376820846107
   PubMedGoogle Scholar
• Hadler-OlsenEFadnesBSylteIUhlin-HansenLWinbergJORegulation of matrix metalloproteinase activity in health and diseaseFEBS J20112781284521087458
   PubMed Web of Science ®Google Scholar
• Hadler-OlsenEWinbergJOUhlin-HansenLMatrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targetsTumor Biol201334420412051
   PubMedGoogle Scholar
• KleinTBischoffRPhysiology and pathophysiology of matrix metal-loproteasesAmino Acids201141227129020640864
   PubMed Web of Science ®Google Scholar
• DeryuginaEIQuigleyJPMatrix metalloproteinases and tumor metastasisCancer Metastasis Rev200625193416680569
   PubMed Web of Science ®Google Scholar
• GoffinFMunautCFrankenneFExpression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometriumBiol Reprod200369397698412773401
   PubMed Web of Science ®Google Scholar
• SkinnerJLRileySCGebbieAEGlasierAFCritchleyHORegulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrelHuman Reprod1999143793799
   PubMed Web of Science ®Google Scholar
• ShanBLiWYangSYLiZREstrogen up-regulates MMP2/9 expression in endometrial epithelial cell via VEGF-ERK1/2 pathwayAsian Pac J Trop Med201361082683023870474
   PubMedGoogle Scholar
• FurukawaYKawanoYFukudaJMatsumotoHNaraharaHThe production of vascular endothelial growth factor and metalloproteinase via protease-activated receptor in human endometrial stromal cellsFertil Steril200991253554118314110
   PubMed Web of Science ®Google Scholar
• JiaWGaoXJZhangZDYangZXZhangGS100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGFEur Rev Med Pharmacol Sci201317111495150823771538
   PubMedGoogle Scholar
• ZhengHTakahashiHMuraiYExpressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinomaAnticancer Res2006265A3579358317094486
   PubMed Web of Science ®Google Scholar
• ZhangQChenXZhouJCD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patientsCancer Biol Ther20065780881416775432
   PubMed Web of Science ®Google Scholar
• ZhangAMengLWangQEnhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2Oncol Rep200615483183616525667
   PubMedGoogle Scholar
• BelottiDCalcagnoCGarofaloAVascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasionMol Cancer Rese200864525534
   PubMed Web of Science ®Google Scholar
• NoriyukiMSumiTZhiXVascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young womenInt J Oncol200731353153617671679
   PubMedGoogle Scholar
• AliEMShetaMEl MohsenMAElevated serum and tissue VEGF associated with poor outcome in breast cancer patientsAlexandria J Med2011473217224
   Google Scholar
• BremnesRMCampsCSireraRAngiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and bloodLung Cancer200651214315816360975
   PubMed Web of Science ®Google Scholar
• BandieraEFranceschiniRSpecchiaCPrognostic significance of vascular endothelial growth factor serum determination in women with ovarian cancerISRN Obstet Gynecol2012201224575622792477
   PubMedGoogle Scholar
• DuKGongHYGongZMInfluence of serum VEGF levels on therapeutic outcome and diagnosis/prognostic value in patients with cervical cancerAsian Pac J Cancer Prev2013152087938796
   Google Scholar
• CrosbyMBYangHGaoWZhangLGrossniklausHESerum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanomaBr J Ophthalmol201195111211720819828
   PubMed Web of Science ®Google Scholar
• RajabiPNeshatAMokhtariMRajabiMAEftekhariMTavakkoliPThe role of VEGF in melanoma progressionJ Res Med Sci201217653453923626629
   PubMedGoogle Scholar
• DaiHZhaoSXuLChenADaiSExpression of Efp, VEGF and bFGF in normal, hyperplastic and malignant endometrial tissueOncol Rep201023379579920127022
   PubMedGoogle Scholar
• Piastowska-CiesielskaAWPłuciennikEWójcik-KrowirandaKBieńkiewiczABednarekAOchędalskiTAnalysis of the expression of angiotensin II type 1 receptor and VEGF in endometrial adenocarcinoma with different clinicopathological characteristicsTumor Biol2012333767774
   PubMedGoogle Scholar
• YangYLiuHLiWExpression of Mta-1 and VEGF and their correlation in the endometrial cancerXi Bao Yu Fen Zi Mian Yi Xue Za Zhi2010267682684 Chinese20619094
   PubMedGoogle Scholar
• NorthSMoennerMBikfalviARecent developments in the regulation of the angiogenic switch by cellular stress factors in tumorsCancer Lett2005218111415639335
   PubMed Web of Science ®Google Scholar
• SaarelainenSKStaffSPeltonenNEndoglin, VEGF, and its receptors in predicting metastases in endometrial carcinomaTumor Biol201435546514657
   PubMedGoogle Scholar
• TopolovecZĆoručićABabićDVascular endothelial growth factor and intratumoral microvessel density as prognostic factors in endometrial cancerColl Antropol201034244745320698116
   PubMedGoogle Scholar
• SouflaGSifakisSPorichisFSpandidosDAPrognostic value of tgfb1 protein in endometrioid adenocarcinomaEur J Clin Invest2013431799023176363
   PubMedGoogle Scholar
• DobrzyckaBMackowiak-MatejczykBKinalskiMTerlikowskiSJPretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinomaGynecol Oncol2013128345446023206584
   PubMed Web of Science ®Google Scholar
• DobrzyckaBTerlikowskiSJKowalczukOKulikowskiMNiklinskiJSerum levels of VEGF and VEGF-C in patients with endometrial cancerEur Cytokine Netw2011221455121411409
   PubMed Web of Science ®Google Scholar
• DobrzyckaBTerlikowskiSKwiatkowskiMGarbowiczMKinalskiMChyczewskiLPrognostic significance of VEGF and its receptors in endometrioid endometrial cancerGinekol Pol201081642242520695190
   PubMed Web of Science ®Google Scholar
• WangXPanZLiAZhuMStudy on the correlation of Xinjiang endometrial tumor and vascular endothelial growth factorZhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi201024298100 Chinese21110424
   PubMedGoogle Scholar
• ParkKSKimSJKimKHKimJCClinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancerJ Gas-troenterol Hepatol2011262391397
   PubMed Web of Science ®Google Scholar
• HuXLiDZhangWZhouJTangBLiLMatrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasionArch Gynecol Obstet201228661537154322832979
   PubMed Web of Science ®Google Scholar
• MinKWKimDHDoSIExpression patterns of stromal MMP-2 and tumoural MMP-2 and -9 are significant prognostic factors in invasive ductal carcinoma of the breastApmis2014122121196120624909183
   PubMed Web of Science ®Google Scholar
• GrybosABarJThe relationships between the immunoexpression of KAI1, MMP-2, MMP-9 and steroid receptors expression in endometrial cancerFolia Histochem Cytobiol201452318719425308734
   PubMed Web of Science ®Google Scholar
• PlanagumàJLiljeströmMAlamedaFMatrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinomaHum Pathol2011421576720970160
   PubMedGoogle Scholar
• WangXChenXExpression and significance of Twist1 and MMP-2 in endometrial endometrioid adenocarcinomaZhonghua Zhong Liu Za Zhi2012348588591 Chinese23158991
   PubMedGoogle Scholar
• WeigelMTKrämerJSchemCDifferential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinomaEur J Obstet Gynecol Reprod Biol20121601747822056701
   PubMed Web of Science ®Google Scholar
• LiSShenXYangZClinical significance of MMP2 overexpression in endometrial adenocarcinomaNan Fang Yi Ke Da Xue Bao2014343423425 Chinese
   PubMedGoogle Scholar
• Honkavuori-ToivolaMSantalaMSoiniYTurpeenniemi-HujanenTTalvensaari-MattilaACombination of strong MMP-2 and weak TIMP-2 immunostainings is a significant prognostic factor in endometrial carcinomaDis Markers201335426126624344400
   PubMedGoogle Scholar
• YuFJiangQZhouYAbnormal expression of matrix metalloproteinase-9 (MMP9) correlates with clinical course in Chinese patients with endometrial cancerDis Markers201232532132722674412
   PubMedGoogle Scholar
• BogusiewiczMStryjecka-ZimmerMRechbergerTActivity of matrix metalloproteinases -2 and -9 (MMP-2 and MMP-9) and content of their tissue inhibitors in endometrial cancer–a preliminary studyGinekol Pol2007785366372 Polish17867327
   PubMedGoogle Scholar
• YilmazEKoyuncuogluMGörkenİBExpression of matrix metalloproteinase-2 and survivin in endometrioid and nonendometrioid endometrial cancers and clinicopathologic significanceJ Gynecol Oncol2011222899621860734
   PubMedGoogle Scholar
• PuljizMPuljizZVucemiloTPrognostic significance of matrix metalloproteinases 2 and 9 in endometrial cancerColl Antropol20123641367137223390835
   PubMedGoogle Scholar
• KarahanNGüneyMBaspinarSOralBKapucuogluNMunganTExpression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinomaEur J Gynaecol Oncol200728318418817624083
   PubMedGoogle Scholar
• AglundKRauvalaMPuistolaUGelatinases A and B (MMP-2 and MMP-9) in endometrial cancer – MMP-9 correlates to the grade and the stageGynecol Oncol200494369970415350361
   PubMedGoogle Scholar
• GraesslinOCortezAFauvetRLorenzatoMBirembautPDaraïEMetalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation studyAnn Oncol200617463764516407419
   PubMedGoogle Scholar
• GraesslinOCortezAUzanCBirembautPQuereuxCDaraïEEndometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressionsInt J Gynecol Cancer20061651911191717009991
   PubMedGoogle Scholar
• HorréeNvan DiestPJvan der GroepPSie-GoDMHeintzAPHypoxia and angiogenesis in endometrioid endometrial carcinogenesisCell Oncol200729321922717452774
   PubMedGoogle Scholar
• GusetGCostiSLazarEExpression of vascular endothelial growth factor (VEGF) and assessment of microvascular density with CD34 as prognostic markers for endometrial carcinomaRom J Morphol Embryol201051467768221103625
   PubMedGoogle Scholar
• WangJTaylorAShoweilRExpression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinomaCytokine20146829410024845798
   PubMed Web of Science ®Google Scholar
• FerraraNChenHDavis-SmythTVascular endothelial growth factor is essential for corpus luteum angiogenesisNat Med1998433363409500609
   PubMed Web of Science ®Google Scholar
• BoglioloSCassaniCGardellaBCurrent opinion on bevacizumab on endometrial cancer treatmentExp Opin Biol Ther2015152299307
   PubMed Web of Science ®Google Scholar
• AghajanianCSillMWDarcyKMPhase II trial of bevacizumab in recurrent or persistent endometrial cancer: a gynecologic oncology group studyJ Clin Oncol201129162259226521537039
   PubMed Web of Science ®Google Scholar